logo-loader
viewPandora Media

Pandora Media, oil stocks, and Costco in the frame before the bell - PRE-MARKET

We are tracking some of the movers ahead of the bell in New York

shutterstock_258183602.jpg
What's hot and what's not in New York?

Oil shares were in focus pre-market and shares were lagging after some analyst comment.

ExxonMobil (NYSE:XOM) shares lost 1.52% to $80.85, while Chevron (NYSE:CVX) shed 1.58% to $104.62 after RBC Capital got out the red pen.

The brokerage firm downgraded Exxon to "sector perform" from "outperform," and cut Chevron to 'underperform' from 'sector perform'

RBC praises Exxon's execution and returns, but adds that the performance is already reflected in the share price.

RBC is bearish on Chevron due to what it sees as a rapid ramp-up in the Permian Basin.

Tesla (NASDAQ:TSLA) shares are taking a pasting and dropped after broker heavyweight Goldman said the stock was worth $180.

Shares closed yesterday at around $319.86.

Elsewhere, Costco (NASDAQ:COST) shares were over 2%  after the warehouse retailer posted a better-than-expected 6 percent rise in same-store sales for June.

Pandora Media Inc (NYSE:P) saw shares nudge up in pre-market to $8.89 as it emerged board members and shareholders at the internet radio firm have former Twitter chief operating officer Adam Bain on a short list to become the streaming service's next chief executive, according to a press report.

Quick facts: Pandora Media

Price: - -

NYSE:P
Market: NYSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Zelira Therapeutics releases interim data for Phase II...

Zelira Therapeutics Ltd (ASX:ZLD) managing director Dr Richard Hopkins, chairman Osagie Imasogie and clinical trial principal investigator Professor Peter Eastwood, of the University of Western Australia, update Proactive on results from the company’s Phase II clinical trial of medicinal...

8 hours, 6 minutes ago

2 min read